Cytokines and lipid peroxidation in alcoholics with chronic hepatitis C virus infection

Alcohol and Alcoholism

Volumn 43, Issue 2, 2008, Pages 137-142

  Castellano Higuera, Ana ^a   González Reimers, Emilio ^a   Alemán Valls, M Remedios ^a   Abreu González, Pedro ^a   Santolaria Fernández, Francisco ^a   de la Vega Prieto, María José ^a   Gómez Sirvent, Juan Luis ^a   Pelazas González, Ricardo ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; MALONALDEHYDE; PROTHROMBIN; RIBAVIRIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROCYTE METABOLISM; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; TH3 CELL;

ADULT; ALCOHOLISM; COHORT STUDIES; CYTOKINES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED;

HEPATITIS C VIRUS;

EID: 41749087885     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agm171     Document Type: Article

References (40)

1. Bird, G. L., Sheron, N., Goka, A. K., Alexander, G. J. and Williams, R. S. (1990) Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Annals of Internal Medicine 112, 917-920.
2. Chen, A. (2002) Acetaldehyde stimulates the activation of latent transforming growth factor beta 1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells. Biochemical Journal 368, 683-693.
3. Chevaliez, S. and Pawlotsky, J. M. (2007) Hepatitis C virus: Virology, diagnosis and management of antiviral therapy. World Journal of Gastroenterology 13, 2461-2466.
4. Crews, F. T., Bechara, R., Brown, L. A. et al. (2006) Cytokines and alcohol. Alcoholism: Clinical and Experimental Research 30, 720-730.
5. Del Rio, D., Stewart, A. J. and Pellegrini, N. (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, Metabolism & Cardiovascular Diseases 15, 316-328.
6. Dikici, I., Mehmetoglu, I., Dikici, N. et al. (2005) Investigation of oxidative stress and some antioxidants in patients with acute and chronic viral hepatitis B and the effect of interferon-alpha treatment. Clinical Biochemistry 38, 1141-1144.
7. Eggers, V., Pascher, A., Althoff, H. et al. (2006) Immune reactivity is more suppressed in patients with alcoholic liver disease than in patients with virus-induced cirrhosis after CRH stimulation. Alcoholism: Clinical and Experimental Research 30, 140-149.
8. Falleti, E., Fabris, C., Toniutto, P. et al. (2007) Genetic polymorphism of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C. Journal of Interferon & Cytokine Research 27, 239-246.
9. Fan, X. G., Liu, W. E., Li, C. Z. et al. (1998) Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection. Mediators of Inflammation 7, 295-297.
10. Fujimoto, M., Uemura, M., Nakatani, Y. et al. (2000) Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: Relation to severity of liver disturbance. Alcoholism: Clinical and Experimental Research 24, 48S-54S.
11. Jarque-López, A., González-Reimers, E., Rodríguez-Moreno, F. et al. (2001) Prevalence and mortality of heavy drinkers in a general Medical Hospital Unit. Alcohol and Alcoholism 36, 335-338.
12. Karatas, F., Karatepe, M. and Baysar, A. (2002) Determination of free malondialdehyde in human serum by high-performance liquid chromatography. Analytical Biochemistry 311, 76-79.
13. Kikugawa, K., Kojima, T., Yamaki, S. et al. (1992) Interpretation of the thiobarbituiic acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid. Analytical Biochemistry 202, 249-255.
14. Ko, W-S., Guo, C.-H., Yeh, M.-S. et al. (2005) Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World Journal of Gastroenterology 11, 4697-4702.
15. Kono, H., Rusyn, I., Yin, M. et al. (2000) NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. Journal of Clinical Investigation 106, 867-872.
16. Kowala-Piaskowska, A., Mozer-Lisewska, I., Figlerowicz, M. et al. (2004) Interleukin 6 and 12, alanine aminotransferase activity, and HCV viral load in children with chronic hepatitis C treated with interferon and ribavirin. Inflammation 28, 319-325.
17. Lee, S., Macquillan, G. C., Keane, N. M. et al. (2002) Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin. Immunology and Cell Biology 80, 391-397.
18. Levent, G., Ali, A., Ahmet, A. et al. (2006) Oxidative stress and antioxidant defense in patients with chronic hepatitis C before and after pegylated interferon alfa-2b plus ribavirin. Journal of Translational Medicine 4, 25. doi:10.1186/1479-5876-4-25
19. Masaki, N., Fukushima, S. and Hayashi, S. (2002) Lower th-1/th-2 ratio before interferon therapy may favour long-term virological responses in patients with chronic hepatitis C. Digestive Diseases and Sciences 47, 2163-2169.
20. Nelson, D. R., González-Peralta, R. P., Qian, K. et al. (1997) Transforming growth factor-beta 1 in chronic hepatitis C. Journal of Viral Hepatitis 4, 29-35.
21. Neuman, M. G., Benhamou, J. P., Malkiewicz, I. M. et al. (2002) Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis. Journal of Viral Hepatitis 9, 134-140.
22. Okuda, M., Li, K., Beard, M. R. et al. (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122, 366-375.
23. Otani, K., Korenaga, M., Beard, M. R. et al. (2005) Hepatitis C virus core protein, cytochrome P-450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 128, 96-107.
24. Paradis, V., Mathurin, P., Kollinger, M. et al. (1997) In situ detection of lipid peroxidation in chronic hepatitis C: Correlation with pathologic features. Journal of Clinical Pathology 50, 401-406.
25. Parsons, C. J., Takashima, M. and Rippe, R. A. (2007) Molecular mechanisms of hepatic fibrogenesis. Journal of Gastroenterology and Hepatology 22 (S1), S79-S84.
26. Plumlee, C. R., Lazaro, C. A., Fausto, N. et al. (2005) Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Virology Journal 2, 89. doi:10.1186/1743-422X-2-89
27. Poynard, T., Bedossa, P. and Opolon, P. (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349, 825-832.
28. Roulot, D., Durand, H., Coste, T. et al. (1995) Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: Absence of correlation between high levels and severity of disease. Hepatology 21, 298-304.
29. Sánchez-Pérez, M. J., González-Reimers, E., Santolaria-Fernández, F. et al. (2006) Lipid peroxidation and serum cytokines in acute alcoholic hepatitis. Alcohol and Alcoholism 41, 593-597.
30. Spanakis, N. E., Garinis, G. A., Alexopoulos, E. C. et al. (2002) Cytokine serum levels in patients with chronic HCV infection. Journal of Clinical Laboratory Analysis 16, 40-46.
31. Takahashi, M., Yamada, G., Miyamoto, R. et al. (1993) Natural history of chronic hepatitis C. American Journal of Gastroenterology 88, 240-243.
32. Taylor, A., Verhagen, J., Blaser, K. et al. (2006) Mechanisms of immune suppression by I110 and TGF-b: The role of T-regulatory cell. Immunology 117, 433-442.
33. Tong, M. J., El-Farra, N. S., Reikes, A. R. et al. (1995) Clinical outcomes after transfusion-associated hepatitis C. New England Journal of Medicine 332, 1463-1466.
34. Torer, N., Ozenirler, S., Yucel, A. et al. (2007) Importance of cytokines, oxidative stress and expression of Bcl-2 in the pathogenesis of non-alcoholic steatohepatitis. Scandinavian Journal of Gastroenterology 42, 1095-1101.
35. Trapero-Marugán, M., García-Buey, L., Muñoz, C. et al. (2006) Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response. Alimentary and Pharmacology & Therapeutics 24, 117-128.
36. Wiley, T. E., McCarthy, M., Breidi, L. et al. (1998) Impact of alcohol on histological and clinical progression on hepatitis C infection. Hepatology 28, 805-809.
37. Yadav, D., Hertna, H. I., Schweitzer, P. et al. (2002) Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. American Journal of Gastroenterology 97, 2634-2639.
38. Yano, M., Yatsuhasi, H., Inoue, O. et al. (1993) Epidemiology and long-term prognosis of hepatitis C virus infection in Japan. Gut 34 (Suppl), 13-16.
39. Yin, M., Wheeler, M. D., Kono, H. et al. (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117, 942-952.
40. Zwolinska, D., Grzeszczak, W., Killis-Pstrunsinska, K. et al. (2004) Lipid peroxidation and antioxidant enzymes in children with chronic renal failure. Pedriatic Nephrology 19, 888-892.